{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:01:09Z","timestamp":1793318469593,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI07422"],"award-info":[{"award-number":["T32AI07422"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI12430"],"award-info":[{"award-number":["U01AI12430"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI12430"],"award-info":[{"award-number":["U01AI12430"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI12430"],"award-info":[{"award-number":["U01AI12430"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI128328"],"award-info":[{"award-number":["R21AI128328"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI07422"],"award-info":[{"award-number":["T32AI07422"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI12430"],"award-info":[{"award-number":["U01AI12430"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI142780"],"award-info":[{"award-number":["U19AI142780"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    is increasingly refractory to antibiotic treatment in healthcare settings. As is true of most human pathogens, the genetic path to antimicrobial resistance (AMR) and the role that the immune system plays in modulating AMR during disease are poorly understood. Here we reproduced several routes to fluoroquinolone resistance, performing evolution experiments using sequential lung infections in mice that are replete with or depleted of neutrophils, providing two key insights into the evolution of drug resistance. First, neutropenic hosts acted as reservoirs for the accumulation of drug resistance during drug treatment. Selection for variants with altered drug sensitivity profiles arose readily in the absence of neutrophils, while immunocompetent animals restricted the appearance of these variants. Secondly, antibiotic treatment failure in the immunocompromised host was shown to occur without clinically defined resistance, an unexpected result that provides a model for how antibiotic failure occurs clinically in the absence of AMR. The genetic mechanism underlying both these results is initiated by mutations activating the drug egress pump regulator AdeL, which drives persistence in the presence of antibiotic. Therefore, antibiotic persistence mutations present a two-pronged risk during disease, causing drug treatment failure in the immunocompromised host while simultaneously increasing the emergence of high-level AMR.\n                  <\/jats:p>","DOI":"10.1038\/s41564-022-01126-8","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T12:04:49Z","timestamp":1653566689000},"page":"796-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5112-1951","authenticated-orcid":false,"given":"Wenwen","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Hernandez-Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Hamami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9661-8072","authenticated-orcid":false,"given":"Edward","family":"Geisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-0765","authenticated-orcid":false,"given":"Vaughn S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-6795","authenticated-orcid":false,"given":"Tim","family":"van Opijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1798-1760","authenticated-orcid":false,"given":"Jason W.","family":"Rosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8330-3554","authenticated-orcid":false,"given":"Ralph R.","family":"Isberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1\u201312 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"1126_CR2","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1128\/JCM.00367-08","volume":"46","author":"SC Valentine","year":"2008","unstructured":"Valentine, S. C. et al. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California. J. Clin. Microbiol. 46, 2499\u20132507 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"1126_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/668770","volume":"34","author":"DM Sievert","year":"2015","unstructured":"Sievert, D. M. et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010. Infect. Control Hosp. Epidemiol. 34, 1\u201314 (2015).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"1126_CR4","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1128\/AAC.00123-06","volume":"50","author":"JA Karlowsky","year":"2006","unstructured":"Karlowsky, J. A., Hoban, D. J., DeCorby, M. R., Laing, N. M. & Zhanel, G. G. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study. Antimicrob. Agents Chemother. 50, 2251\u20132254 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1126_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1099\/jmm.0.018085-0","volume":"59","author":"A Azim","year":"2010","unstructured":"Azim, A. et al. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum \u03b2-lactamase- and metallo-\u03b2-lactamase-producing Gram-negative bacteria \u2013 an Indian experience. J. Med. Microbiol. 59, 955\u2013960 (2010).","journal-title":"J. Med. Microbiol."},{"key":"1126_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4037\/ccn2008.28.1.15","volume":"28","author":"K Montefour","year":"2008","unstructured":"Montefour, K. et al. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit. Care Nurse 28, 15\u201325 (2008).","journal-title":"Crit. Care Nurse"},{"key":"1126_CR7","doi-asserted-by":"publisher","unstructured":"Zeighami, H., Valadkhani, F., Shapouri, R., Samadi, E. & Haghi, F. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infect. Dis. https:\/\/doi.org\/10.1186\/s12879-019-4272-0 (2019).","DOI":"10.1186\/s12879-019-4272-0"},{"key":"1126_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nrmicro1789","volume":"5","author":"L Dijkshoorn","year":"2007","unstructured":"Dijkshoorn, L., Nemec, A. & Seifert, H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5, 939\u2013951 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"1126_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jinf.2018.04.002","volume":"77","author":"K Ryan","year":"2018","unstructured":"Ryan, K. et al. The impact of initial antibiotic treatment failure: real-world insights in healthcare-associated or nosocomial pneumonia. J. Infect. 77, 9\u201317 (2018).","journal-title":"J. Infect."},{"key":"1126_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/CMR.00058-16","volume":"30","author":"D Wong","year":"2017","unstructured":"Wong, D. et al. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin. Microbiol Rev. 30, 409\u2013447 (2017).","journal-title":"Clin. Microbiol Rev."},{"key":"1126_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/jac\/dkg097","volume":"51","author":"F Fernandez-Cuenca","year":"2003","unstructured":"Fernandez-Cuenca, F. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51, 565\u2013574 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"1126_CR12","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1128\/AAC.00116-06","volume":"50","author":"K Lolans","year":"2006","unstructured":"Lolans, K., Rice, T. W., Munoz-Price, L. S. & Quinn, J. P. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob. Agents Chemother. 50, 2941\u20132945 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1126_CR13","doi-asserted-by":"publisher","first-page":"e1004691","DOI":"10.1371\/journal.ppat.1004691","volume":"11","author":"E Geisinger","year":"2015","unstructured":"Geisinger, E. & Isberg, R. R. Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS Pathog. 11, e1004691 (2015).","journal-title":"PLoS Pathog."},{"key":"1126_CR14","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","volume":"53","author":"KJ Aldred","year":"2014","unstructured":"Aldred, K. J., Kerns, R. J. & Osheroff, N. Mechanism of quinolone action and resistance. Biochemistry 53, 1565\u20131574 (2014).","journal-title":"Biochemistry"},{"key":"1126_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","volume":"22","author":"LS Redgrave","year":"2014","unstructured":"Redgrave, L. S., Sutton, S. B., Webber, M. A. & Piddock, L. J. V. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 22, 438\u2013445 (2014).","journal-title":"Trends Microbiol."},{"key":"1126_CR16","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/JCM.02380-08","volume":"47","author":"KM Hujer","year":"2009","unstructured":"Hujer, K. M. et al. Rapid determination of quinolone resistance in Acinetobacter spp. J. Clin. Microbiol. 47, 1436\u20131442 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"1126_CR17","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1056\/NEJMra070741","volume":"358","author":"LS Munoz-Price","year":"2008","unstructured":"Munoz-Price, L. S. & Weinstein, R. A. Acinetobacter infection. N. Engl. J. Med. 358, 1271\u20131281 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1126_CR18","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.1073\/pnas.1400352111","volume":"111","author":"P Ankomah","year":"2014","unstructured":"Ankomah, P. & Levin, B. R. Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections. Proc. Natl Acad. Sci. USA 111, 8331\u20138338 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1126_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22814-9","volume":"12","author":"R Wheatley","year":"2021","unstructured":"Wheatley, R. et al. Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection. Nat. Commun. 12, 2460 (2021).","journal-title":"Nat. Commun."},{"key":"1126_CR20","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1128\/AAC.00739-12","volume":"56","author":"SD Saroj","year":"2012","unstructured":"Saroj, S. D., Clemmer, K. M., Bonomo, R. A. & Rather, P. N. Novel mechanism for fluoroquinolone resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 56, 4955\u20134957 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1126_CR21","doi-asserted-by":"publisher","first-page":"10818","DOI":"10.1007\/s11356-016-6221-4","volume":"23","author":"A Osi\u0144ska","year":"2016","unstructured":"Osi\u0144ska, A., Harnisz, M. & Korzeniewska, E. Prevalence of plasmid-mediated multidrug resistance determinants in fluoroquinolone-resistant bacteria isolated from sewage and surface water. Environ. Sci. Pollut. Res. 23, 10818\u201310831 (2016).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"1126_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.micpath.2018.12.039","volume":"128","author":"NM Elhosseiny","year":"2019","unstructured":"Elhosseiny, N. M., Elhezawy, N. B. & Attia, A. S. Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance. Microb. Pathog. 128, 20\u201327 (2019).","journal-title":"Microb. Pathog."},{"key":"1126_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-55","volume":"6","author":"AF Zuluaga","year":"2006","unstructured":"Zuluaga, A. F. et al. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect. Dis. 6, 55 (2006).","journal-title":"BMC Infect. Dis."},{"key":"1126_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1084\/jem.155.4.1063","volume":"155","author":"RJ North","year":"1982","unstructured":"North, R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J. Exp. Med. 155, 1063\u20131074 (1982).","journal-title":"J. Exp. Med."},{"key":"1126_CR25","doi-asserted-by":"publisher","unstructured":"Yoon, E. J. et al. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii. mBio https:\/\/doi.org\/10.1128\/mBio.00309-15 (2015).","DOI":"10.1128\/mBio.00309-15"},{"key":"1126_CR26","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1128\/AAC.00155-10","volume":"54","author":"S Coyne","year":"2010","unstructured":"Coyne, S., Rosenfeld, N., Lambert, T., Courvalin, P. & Perichon, B. Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 4389\u20134393 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1126_CR27","unstructured":"Breakpoint Tables for Interpretation of MIC and Zone Diameter Results Version 6.0 (The United States Committee on Antimicrobial Susceptibility Testing (USCAST), 2020)."},{"key":"1126_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner, A., Fridman, O., Gefen, O. & Balaban, N. Q. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat. Rev. Microbiol. 14, 320\u2013330 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"1126_CR29","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1534\/genetics.104.035352","volume":"169","author":"E Kussell","year":"2005","unstructured":"Kussell, E., Kishony, R., Balaban, N. Q. & Leibler, S. Bacterial persistence: a model of survival in changing environments. Genetics 169, 1807\u20131814 (2005).","journal-title":"Genetics"},{"key":"1126_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.gde.2011.10.001","volume":"21","author":"NQ Balaban","year":"2011","unstructured":"Balaban, N. Q. Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr. Opin. Genet. Dev. 21, 768\u2013775 (2011).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"1126_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","volume":"17","author":"NQ Balaban","year":"2019","unstructured":"Balaban, N. Q. et al. Definitions and guidelines for research on antibiotic persistence. Nat. Rev. Microbiol. 17, 441\u2013448 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"1126_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1126\/science.aay3041","volume":"367","author":"J Liu","year":"2020","unstructured":"Liu, J., Gefen, O., Ronin, I., Bar-Meir, M. & Balaban, N. Q. Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science 367, 200\u2013204 (2020).","journal-title":"Science"},{"key":"1126_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17735-y","volume":"11","author":"A Papkou","year":"2020","unstructured":"Papkou, A., Hedge, J., Kapel, N., Young, B. & MacLean, R. C. Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates. Nat. Commun. 11, 3970 (2020).","journal-title":"Nat. Commun."},{"key":"1126_CR34","doi-asserted-by":"publisher","unstructured":"Santos-Lopez, A., Marshall, C. W., Scribner, M. R., Snyder, D. J. & Cooper, V. S. Evolutionary pathways to antibiotic resistance are dependent upon environmental structure and bacterial lifestyle. eLife https:\/\/doi.org\/10.7554\/eLife.47612 (2019).","DOI":"10.7554\/eLife.47612"},{"key":"1126_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.biochem.76.010307.145803","volume":"76","author":"CRH Raetz","year":"2007","unstructured":"Raetz, C. R. H., Reynolds, C. M., Trent, M. S. & Bishop, R. E. Lipid A modification systems in Gram-negative bacteria. Annu. Rev. Biochem. 76, 295\u2013329 (2007).","journal-title":"Annu. Rev. Biochem."},{"key":"1126_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00265576","volume":"154","author":"R Lathe","year":"1977","unstructured":"Lathe, R. & Lecocq, J. P. The firA gene, a locus involved in the expression of rifampicin resistance in Escherichia coli. Mol. Gen. Genet. 154, 53\u201360 (1977).","journal-title":"Mol. Gen. Genet."},{"key":"1126_CR37","doi-asserted-by":"publisher","first-page":"19866","DOI":"10.1016\/S0021-9258(19)36593-7","volume":"268","author":"TM Kelly","year":"1993","unstructured":"Kelly, T. M., Stachula, S. A., Raetz, C. R. & Anderson, M. S. The firA gene of Escherichia coli encodes UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase. The third step of endotoxin biosynthesis. J. Biol. Chem. 268, 19866\u201319874 (1993).","journal-title":"J. Biol. Chem."},{"key":"1126_CR38","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1073\/pnas.0606356104","volume":"104","author":"L Buetow","year":"2007","unstructured":"Buetow, L., Smith, T. K., Dawson, A., Fyffe, S. & Hunter, W. N. Structure and reactivity of LpxD, the N-acyltransferase of lipid A biosynthesis. Proc. Natl Acad. Sci. USA 104, 4321\u20134326 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1126_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","volume":"3","author":"KA Jolley","year":"2018","unstructured":"Jolley, K. A., Bray, J. E. & Maiden, M. C. J. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 3, 124 (2018).","journal-title":"Wellcome Open Res"},{"key":"1126_CR40","doi-asserted-by":"publisher","unstructured":"Blount, Z. D., Lenski, R. E. & Losos, J. B. Contingency and determinism in evolution: replaying life\u2019s tape. Science https:\/\/doi.org\/10.1126\/science.aam5979 (2018).","DOI":"10.1126\/science.aam5979"},{"key":"1126_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/eva.12196","volume":"8","author":"AH Melnyk","year":"2014","unstructured":"Melnyk, A. H., Wong, A. & Kassen, R. The fitness costs of antibiotic resistance mutations. Evol. Appl. 8, 273\u2013283 (2014).","journal-title":"Evol. Appl."},{"key":"1126_CR42","doi-asserted-by":"publisher","unstructured":"Subedi, D., Vijay, A. K., Kohli, G. S., Rice, S. A. & Willcox, M. Comparative genomics of clinical strains of Pseudomonas aeruginosa strains isolated from different geographic sites. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-34020-7 (2018).","DOI":"10.1038\/s41598-018-34020-7"},{"key":"1126_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/ng.2848","volume":"46","author":"TD Lieberman","year":"2013","unstructured":"Lieberman, T. D. et al. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat. Genet. 46, 82\u201387 (2013).","journal-title":"Nat. Genet."},{"key":"1126_CR44","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/ng.997","volume":"43","author":"TD Lieberman","year":"2011","unstructured":"Lieberman, T. D. et al. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat. Genet. 43, 1275\u20131280 (2011).","journal-title":"Nat. Genet."},{"key":"1126_CR45","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMc2031364","volume":"383","author":"B Choi","year":"2020","unstructured":"Choi, B. et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 383, 2291\u20132293 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1126_CR46","doi-asserted-by":"publisher","unstructured":"Honsa, E. S. et al. RelA mutant Enterococcus faecium with multiantibiotic tolerance arising in an immunocompromised host. mBio https:\/\/doi.org\/10.1128\/mBio.02124-16 (2017).","DOI":"10.1128\/mBio.02124-16"},{"key":"1126_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1128\/MMBR.00055-15","volume":"80","author":"C Ma","year":"2016","unstructured":"Ma, C., Yang, X. & Lewis, P. J. Bacterial transcription as a target for antibacterial drug development. Microbiol. Mol. Biol. Rev. 80, 139\u2013160 (2016).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1126_CR48","doi-asserted-by":"publisher","unstructured":"van Hoek, A. H. A. M. et al. Acquired antibiotic resistance genes: an overview. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2011.00203 (2011).","DOI":"10.3389\/fmicb.2011.00203"},{"key":"1126_CR49","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1128\/jb.155.2.768-775.1983","volume":"155","author":"HS Moyed","year":"1983","unstructured":"Moyed, H. S. & Bertrand, K. P. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155, 768\u2013775 (1983).","journal-title":"J. Bacteriol."},{"key":"1126_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature14662","volume":"524","author":"MA Schumacher","year":"2015","unstructured":"Schumacher, M. A. et al. HipBA-promoter structures reveal the basis of heritable multidrug tolerance. Nature 524, 59\u201364 (2015).","journal-title":"Nature"},{"key":"1126_CR51","doi-asserted-by":"publisher","unstructured":"Pontes, M. H., Groisman, E. A. & Garsin, D. A. A physiological basis for nonheritable antibiotic resistance. mBio https:\/\/doi.org\/10.1128\/mBio.00817-20 (2020).","DOI":"10.1128\/mBio.00817-20"},{"key":"1126_CR52","doi-asserted-by":"publisher","unstructured":"Trastoy, R. et al. Mechanisms of bacterial tolerance and persistence in the gastrointestinal and respiratory environments. Clin. Microbiol. Rev. https:\/\/doi.org\/10.1128\/cmr.00023-18 (2018).","DOI":"10.1128\/cmr.00023-18"},{"key":"1126_CR53","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1126\/science.1099390","volume":"305","author":"NQ Balaban","year":"2004","unstructured":"Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L. & Leibler, S. Bacterial persistence as a phenotypic switch. Science 305, 1622\u20131625 (2004).","journal-title":"Science"},{"key":"1126_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrmicro1557","volume":"5","author":"K Lewis","year":"2007","unstructured":"Lewis, K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5, 48\u201356 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"1126_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2180-6-53","volume":"6","author":"D Shah","year":"2006","unstructured":"Shah, D. et al. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 6, 53 (2006).","journal-title":"BMC Microbiol."},{"key":"1126_CR56","doi-asserted-by":"publisher","unstructured":"Nandakumar, M., Nathan, C. & Rhee, K. Y. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nat. Commun. https:\/\/doi.org\/10.1038\/ncomms5306 (2014).","DOI":"10.1038\/ncomms5306"},{"key":"1126_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.drup.2016.10.002","volume":"29","author":"JE Michiels","year":"2016","unstructured":"Michiels, J. E., Van den Bergh, B., Verstraeten, N. & Michiels, J. Molecular mechanisms and clinical implications of bacterial persistence. Drug Resist. Updates 29, 76\u201389 (2016).","journal-title":"Drug Resist. Updates"},{"key":"1126_CR58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","volume":"15","author":"RA Fisher","year":"2017","unstructured":"Fisher, R. A., Gollan, B. & Helaine, S. Persistent bacterial infections and persister cells. Nat. Rev. Microbiol. 15, 453\u2013464 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"1126_CR59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/femsre\/fux001","volume":"41","author":"B Van den Bergh","year":"2017","unstructured":"Van den Bergh, B., Fauvart, M. & Michiels, J. Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiol. Rev. 41, 219\u2013251 (2017).","journal-title":"FEMS Microbiol. Rev."},{"key":"1126_CR60","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1128\/AAC.02556-12","volume":"57","author":"EJ Yoon","year":"2013","unstructured":"Yoon, E. J., Courvalin, P. & Grillot-Courvalin, C. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob. Agents Chemother. 57, 2989\u20132995 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1126_CR61","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.molcel.2016.03.035","volume":"62","author":"Y Pu","year":"2016","unstructured":"Pu, Y. et al. Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol. Cell 62, 284\u2013294 (2016).","journal-title":"Mol. Cell"},{"key":"1126_CR62","doi-asserted-by":"publisher","unstructured":"Harms, A., Maisonneuve, E. & Gerdes, K. Mechanisms of bacterial persistence during stress and antibiotic exposure. Science https:\/\/doi.org\/10.1126\/science.aaf4268 (2016).","DOI":"10.1126\/science.aaf4268"},{"key":"1126_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tim.2019.01.005","volume":"27","author":"J Frimodt-M\u00f8ller","year":"2019","unstructured":"Frimodt-M\u00f8ller, J. & L\u00f8bner-Olesen, A. Efflux-pump upregulation: from tolerance to high-level antibiotic resistance? Trends Microbiol. 27, 291\u2013293 (2019).","journal-title":"Trends Microbiol."},{"key":"1126_CR64","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1126\/science.aar7981","volume":"362","author":"I El Meouche","year":"2018","unstructured":"El Meouche, I. & Dunlop, M. J. Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation. Science 362, 686\u2013690 (2018).","journal-title":"Science"},{"key":"1126_CR65","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1126\/science.aav6390","volume":"364","author":"S Nolivos","year":"2019","unstructured":"Nolivos, S. et al. Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer. Science 364, 778\u2013782 (2019).","journal-title":"Science"},{"key":"1126_CR66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2147\/IDR.S184116","volume":"12","author":"P Peeters","year":"2019","unstructured":"Peeters, P. et al. The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection. Infect. Drug Resist. 12, 329\u2013343 (2019).","journal-title":"Infect. Drug Resist."},{"key":"1126_CR67","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/jac\/dkz559","volume":"75","author":"A Soriano","year":"2020","unstructured":"Soriano, A., Mensa, J., Meylan, S., Morata, L. & Kuehl, R. When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus. J. Antimicrob. Chemother. 75, 1071\u20131086 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"1126_CR68","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.cell.2018.01.037","volume":"172","author":"S Meylan","year":"2018","unstructured":"Meylan, S., Andrews, I. W. & Collins, J. J. Targeting antibiotic tolerance, pathogen by pathogen. Cell 172, 1228\u20131238 (2018).","journal-title":"Cell"},{"key":"1126_CR69","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jinf.2017.11.001","volume":"76","author":"S Karve","year":"2018","unstructured":"Karve, S. et al. The impact of initial antibiotic treatment failure: real-world insights in patients with complicated urinary tract infection. J. Infect. 76, 121\u2013131 (2018).","journal-title":"J. Infect."},{"key":"1126_CR70","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1128\/IAI.70.8.4226-4238.2002","volume":"70","author":"E Wang","year":"2002","unstructured":"Wang, E. et al. Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice. Infect. Immun. 70, 4226\u20134238 (2002).","journal-title":"Infect. Immun."},{"key":"1126_CR71","doi-asserted-by":"publisher","unstructured":"Nielsen, T. B., Yan, J., Luna, B. & Spellberg, B. Murine oropharyngeal aspiration model of ventilator-associated and hospital-acquired bacterial pneumonia. J. Vis. Exp. https:\/\/doi.org\/10.3791\/57672 (2018).","DOI":"10.3791\/57672"},{"key":"1126_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/genetics\/143.1.15","volume":"143","author":"M Travisano","year":"1996","unstructured":"Travisano, M. & Lenski, R. E. Long-term experimental evolution in Escherichia coli. IV. Targets of selection and the specificity of adaptation. Genetics 143, 15\u201326 (1996).","journal-title":"Genetics"},{"key":"1126_CR73","doi-asserted-by":"publisher","first-page":"e1007030","DOI":"10.1371\/journal.ppat.1007030","volume":"14","author":"E Geisinger","year":"2018","unstructured":"Geisinger, E., Mortman, N. J., Vargas-Cuebas, G., Tai, A. K. & Isberg, R. R. A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii. PLoS Pathog. 14, e1007030 (2018).","journal-title":"PLoS Pathog."},{"key":"1126_CR74","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","volume":"1151","author":"DE Deatherage","year":"2014","unstructured":"Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 1151, 165\u2013188 (2014).","journal-title":"Methods Mol. Biol."},{"key":"1126_CR75","doi-asserted-by":"publisher","first-page":"e0045421","DOI":"10.1128\/IAI.00454-21","volume":"89","author":"CDM Wijers","year":"2021","unstructured":"Wijers, C. D. M. et al. Identification of two variants of Acinetobacter baumannii strain ATCC 17978 with distinct genotypes and phenotypes. Infect. Immun. 89, e0045421 (2021).","journal-title":"Infect. Immun."},{"key":"1126_CR76","doi-asserted-by":"publisher","first-page":"e46688","DOI":"10.1371\/journal.pone.0046688","volume":"7","author":"Y Choi","year":"2012","unstructured":"Choi, Y., Sims, G. E., Murphy, S., Miller, J. R. & Chan, A. P. Predicting the functional effect of amino acid substitutions and indels. PLoS ONE 7, e46688 (2012).","journal-title":"PLoS ONE"},{"key":"1126_CR77","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0378-1119(85)90120-9","volume":"33","author":"C Yanisch-Perron","year":"1985","unstructured":"Yanisch-Perron, C., Vieira, J. & Messing, J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectors. Gene 33, 103\u2013119 (1985).","journal-title":"Gene"},{"key":"1126_CR78","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1128\/IAI.66.3.950-958.1998","volume":"66","author":"HL Andrews","year":"1998","unstructured":"Andrews, H. L., Vogel, J. P. & Isberg, R. R. Identification of linked Legionella pneumophila genes essential for intracellular growth and evasion of the endocytic pathway. Infect. Immun. 66, 950\u2013958 (1998).","journal-title":"Infect. Immun."},{"key":"1126_CR79","doi-asserted-by":"publisher","unstructured":"Katz, L. S. et al. Mashtree: a rapid comparison of whole genome sequence files. J. Open Source Softw. https:\/\/doi.org\/10.21105\/joss.01762 (2019).","DOI":"10.21105\/joss.01762"},{"key":"1126_CR80","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","volume":"16","author":"Du","year":"2021","unstructured":"Du, Z. et al. The trRosetta server for fast and accurate protein structure prediction. Nat. Protoc. 16, 5634\u20135651 (2021).","journal-title":"Nat. Protoc."},{"key":"1126_CR81","doi-asserted-by":"publisher","unstructured":"Su, H. et al. Improved protein structure prediction using a new multi-scale network and homologous templates. Adv. Sci. https:\/\/doi.org\/10.1002\/advs.202102592 (2021).","DOI":"10.1002\/advs.202102592"},{"key":"1126_CR82","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1073\/pnas.1914677117","volume":"117","author":"Yang","year":"2020","unstructured":"Yang et al. Improved protein structure prediction using predicted interresidue orientations. Proc. Natl Acad. Sci. USA 117, 1496\u20131503 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1126_CR83","doi-asserted-by":"publisher","unstructured":"Davis, J. J. et al. The PATRIC Bioinformatics Resource Center: expanding data and analysis capabilities. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkz943 (2019).","DOI":"10.1093\/nar\/gkz943"}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-022-01126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-022-01126-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-022-01126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:48:50Z","timestamp":1669283330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-022-01126-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":83,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1038\/s41564-022-01126-8","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}